Syria Conflict Squeezes Drug Supplies for Major Diseases, WHO Says
This article was originally published in PharmAsia News
Syria’s local production of medicines, once 90% of the nation’s consumption, has been greatly reduced by the civil war in the country, particularly in the provinces of Aleppo, Damascus and Homs where local drug makers tended to congregate.
You may also be interested in...
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.
Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism.
The Belgian biotech has divested its drug discovery services unit in Croatia which was making a nice profit but was not a priority as Galapagos concentrates on setting up its commercial operations in Europe.